http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 07 May 2026 08:44:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html <p align="justify">DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, will be featured at the <b>American Thoracic Society’s (ATS) 2026 Respiratory Innovation Summit (RIS)</b>, taking place May 15–16 in Orlando, Florida. Polarean will also participate in the <b>ATS 2026 International Conference</b> from May 17–20, engaging with leaders across pulmonary medicine, research, and drug development. <br/><br/>The Company’s presence across both RIS and ATS reflects its expanding role at the intersection of clinical research and pharmaceutical innovation, as Xenon MRI continues to evolve into a practical cardiopulmonary biomarker http://www.streetinsider.com/Press+Releases/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html Thu, 07 May 2026 08:44:00 -0400 A.50114135 O.05733547 POLX http://www.streetinsider.com/Press+Releases/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html <p align="justify">DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, will be featured at the <b>American Thoracic Society’s (ATS) 2026 Respiratory Innovation Summit (RIS)</b>, taking place May 15–16 in Orlando, Florida. Polarean will also participate in the <b>ATS 2026 International Conference</b> from May 17–20, engaging with leaders across pulmonary medicine, research, and drug development. <br/><br/>The Company’s presence across both RIS and ATS reflects its expanding role at the intersection of clinical research and pharmaceutical innovation, as Xenon MRI continues to evolve into a practical cardiopulmonary biomarker http://www.streetinsider.com/Press+Releases/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html Thu, 07 May 2026 08:44:00 -0400 A.50114135 O.05733547 POLX http://www.streetinsider.com/Press+Releases/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html <p align="justify">DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, will be featured at the <b>American Thoracic Society’s (ATS) 2026 Respiratory Innovation Summit (RIS)</b>, taking place May 15–16 in Orlando, Florida. Polarean will also participate in the <b>ATS 2026 International Conference</b> from May 17–20, engaging with leaders across pulmonary medicine, research, and drug development. <br/><br/>The Company’s presence across both RIS and ATS reflects its expanding role at the intersection of clinical research and pharmaceutical innovation, as Xenon MRI continues to evolve into a practical cardiopulmonary biomarker http://www.streetinsider.com/Press+Releases/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html Thu, 07 May 2026 08:44:00 -0400 A.50114135 O.05733547 POLX http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html <p align="justify">DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, will be featured at the <b>American Thoracic Society’s (ATS) 2026 Respiratory Innovation Summit (RIS)</b>, taking place May 15–16 in Orlando, Florida. Polarean will also participate in the <b>ATS 2026 International Conference</b> from May 17–20, engaging with leaders across pulmonary medicine, research, and drug development. <br/><br/>The Company’s presence across both RIS and ATS reflects its expanding role at the intersection of clinical research and pharmaceutical innovation, as Xenon MRI continues to evolve into a practical cardiopulmonary biomarker http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html Thu, 07 May 2026 08:44:00 -0400 A.50114135 O.05733547 POLX http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html <p align="justify">DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, will be featured at the <b>American Thoracic Society’s (ATS) 2026 Respiratory Innovation Summit (RIS)</b>, taking place May 15–16 in Orlando, Florida. Polarean will also participate in the <b>ATS 2026 International Conference</b> from May 17–20, engaging with leaders across pulmonary medicine, research, and drug development. <br/><br/>The Company’s presence across both RIS and ATS reflects its expanding role at the intersection of clinical research and pharmaceutical innovation, as Xenon MRI continues to evolve into a practical cardiopulmonary biomarker http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html Thu, 07 May 2026 08:44:00 -0400 A.50114135 O.05733547 POLX http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html <p align="justify">DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, will be featured at the <b>American Thoracic Society’s (ATS) 2026 Respiratory Innovation Summit (RIS)</b>, taking place May 15–16 in Orlando, Florida. Polarean will also participate in the <b>ATS 2026 International Conference</b> from May 17–20, engaging with leaders across pulmonary medicine, research, and drug development. <br/><br/>The Company’s presence across both RIS and ATS reflects its expanding role at the intersection of clinical research and pharmaceutical innovation, as Xenon MRI continues to evolve into a practical cardiopulmonary biomarker http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Advances+as+a+Cardiopulmonary+Biomarker+Platform+at+ATS+2026/26449349.html Thu, 07 May 2026 08:44:00 -0400 A.50114135 O.05733547 POLX http://www.streetinsider.com/Press+Releases/Xenon+MRI+Featured+Prominently+at+ATS+2025+Across+Broad+Clinical+Spectrum/24802571.html <p>DURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, will be featured at the <strong>American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit (RIS)</strong>, taking place May 16–17 at the Marriott Marquis in San Francisco, California. Polarean will also attend the <strong>ATS 2025 International Conference</strong> from May 18–21, continuing its active engagement with leaders across pulmonary medicine.<br/><br/>Polarean’s selection as a featured company at RIS 2025 underscores the growing recognition of the company’s Xenon MRI http://www.streetinsider.com/Press+Releases/Xenon+MRI+Featured+Prominently+at+ATS+2025+Across+Broad+Clinical+Spectrum/24802571.html Thu, 15 May 2025 08:49:00 -0400 O.30562654 POLX http://www.streetinsider.com/Press+Releases/Xenon+MRI+Featured+Prominently+at+ATS+2025+Across+Broad+Clinical+Spectrum/24802571.html <p>DURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, will be featured at the <strong>American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit (RIS)</strong>, taking place May 16–17 at the Marriott Marquis in San Francisco, California. Polarean will also attend the <strong>ATS 2025 International Conference</strong> from May 18–21, continuing its active engagement with leaders across pulmonary medicine.<br/><br/>Polarean’s selection as a featured company at RIS 2025 underscores the growing recognition of the company’s Xenon MRI http://www.streetinsider.com/Press+Releases/Xenon+MRI+Featured+Prominently+at+ATS+2025+Across+Broad+Clinical+Spectrum/24802571.html Thu, 15 May 2025 08:49:00 -0400 O.30562654 POLX http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Featured+Prominently+at+ATS+2025+Across+Broad+Clinical+Spectrum/24802571.html <p>DURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, will be featured at the <strong>American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit (RIS)</strong>, taking place May 16–17 at the Marriott Marquis in San Francisco, California. Polarean will also attend the <strong>ATS 2025 International Conference</strong> from May 18–21, continuing its active engagement with leaders across pulmonary medicine.<br/><br/>Polarean’s selection as a featured company at RIS 2025 underscores the growing recognition of the company’s Xenon MRI http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Featured+Prominently+at+ATS+2025+Across+Broad+Clinical+Spectrum/24802571.html Thu, 15 May 2025 08:49:00 -0400 O.30562654 POLX http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Featured+Prominently+at+ATS+2025+Across+Broad+Clinical+Spectrum/24802571.html <p>DURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, will be featured at the <strong>American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit (RIS)</strong>, taking place May 16–17 at the Marriott Marquis in San Francisco, California. Polarean will also attend the <strong>ATS 2025 International Conference</strong> from May 18–21, continuing its active engagement with leaders across pulmonary medicine.<br/><br/>Polarean’s selection as a featured company at RIS 2025 underscores the growing recognition of the company’s Xenon MRI http://www.streetinsider.com/Globe+Newswire/Xenon+MRI+Featured+Prominently+at+ATS+2025+Across+Broad+Clinical+Spectrum/24802571.html Thu, 15 May 2025 08:49:00 -0400 O.30562654 POLX http://www.streetinsider.com/Press+Releases/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html <p align="justify">DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, to expand access to Polarean’s cutting-edge Xenon MRI platform.</p> <p align="justify">SimonMed Imaging operates in over 170 facilities across 11 states, offering comprehensive medical imaging with cutting-edge technology and artificial intelligence, all with an emphasis on affordability and accessibility. This collaboration will http://www.streetinsider.com/Press+Releases/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html Tue, 28 Jan 2025 08:29:00 -0400 A.24245977 O.30562654 O.50073996 POLX http://www.streetinsider.com/Press+Releases/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html <p align="justify">DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, to expand access to Polarean’s cutting-edge Xenon MRI platform.</p> <p align="justify">SimonMed Imaging operates in over 170 facilities across 11 states, offering comprehensive medical imaging with cutting-edge technology and artificial intelligence, all with an emphasis on affordability and accessibility. This collaboration will http://www.streetinsider.com/Press+Releases/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html Tue, 28 Jan 2025 08:29:00 -0400 A.24245977 O.30562654 O.50073996 POLX http://www.streetinsider.com/Press+Releases/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html <p align="justify">DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, to expand access to Polarean’s cutting-edge Xenon MRI platform.</p> <p align="justify">SimonMed Imaging operates in over 170 facilities across 11 states, offering comprehensive medical imaging with cutting-edge technology and artificial intelligence, all with an emphasis on affordability and accessibility. This collaboration will http://www.streetinsider.com/Press+Releases/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html Tue, 28 Jan 2025 08:29:00 -0400 A.24245977 O.30562654 O.50073996 POLX http://www.streetinsider.com/Press+Releases/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html <p align="justify">DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, to expand access to Polarean’s cutting-edge Xenon MRI platform.</p> <p align="justify">SimonMed Imaging operates in over 170 facilities across 11 states, offering comprehensive medical imaging with cutting-edge technology and artificial intelligence, all with an emphasis on affordability and accessibility. This collaboration will http://www.streetinsider.com/Press+Releases/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html Tue, 28 Jan 2025 08:29:00 -0400 A.24245977 O.30562654 O.50073996 POLX http://www.streetinsider.com/Globe+Newswire/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html <p align="justify">DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, to expand access to Polarean’s cutting-edge Xenon MRI platform.</p> <p align="justify">SimonMed Imaging operates in over 170 facilities across 11 states, offering comprehensive medical imaging with cutting-edge technology and artificial intelligence, all with an emphasis on affordability and accessibility. This collaboration will http://www.streetinsider.com/Globe+Newswire/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html Tue, 28 Jan 2025 08:29:00 -0400 A.24245977 O.30562654 O.50073996 POLX http://www.streetinsider.com/Globe+Newswire/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html <p align="justify">DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, to expand access to Polarean’s cutting-edge Xenon MRI platform.</p> <p align="justify">SimonMed Imaging operates in over 170 facilities across 11 states, offering comprehensive medical imaging with cutting-edge technology and artificial intelligence, all with an emphasis on affordability and accessibility. This collaboration will http://www.streetinsider.com/Globe+Newswire/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html Tue, 28 Jan 2025 08:29:00 -0400 A.24245977 O.30562654 O.50073996 POLX http://www.streetinsider.com/Globe+Newswire/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html <p align="justify">DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, to expand access to Polarean’s cutting-edge Xenon MRI platform.</p> <p align="justify">SimonMed Imaging operates in over 170 facilities across 11 states, offering comprehensive medical imaging with cutting-edge technology and artificial intelligence, all with an emphasis on affordability and accessibility. This collaboration will http://www.streetinsider.com/Globe+Newswire/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html Tue, 28 Jan 2025 08:29:00 -0400 A.24245977 O.30562654 O.50073996 POLX http://www.streetinsider.com/Globe+Newswire/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html <p align="justify">DURHAM, NC and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage leader in advanced medical imaging focused on functional Magnetic Resonance Imaging (&quot;MRI&quot;) of the lungs, announces a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, to expand access to Polarean’s cutting-edge Xenon MRI platform.</p> <p align="justify">SimonMed Imaging operates in over 170 facilities across 11 states, offering comprehensive medical imaging with cutting-edge technology and artificial intelligence, all with an emphasis on affordability and accessibility. This collaboration will http://www.streetinsider.com/Globe+Newswire/Polarean+and+SimonMed+Announce+Collaboration+to+Advance+Lung+Imaging+Innovation/24256033.html Tue, 28 Jan 2025 08:29:00 -0400 A.24245977 O.30562654 O.50073996 POLX